Portuguese propolis disturbs glycolytic metabolism of human colorectal cancer in vitro

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Valença, Isabel ^a,b   Morais Santos, Filipa ^a,b   Miranda Gonçalves, Vera ^a,b   Ferreira, Ana M ^c   Almeida Aguiar, Cristina ^b   Baltazar, Fátima ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Antitumor activity; Colorectal cancer; Glycolytic metabolism; HCT 15 cells; Propolis

Indexed keywords

ALCOHOL; ANEXIN V; ANTINEOPLASTIC AGENT; BROXURIDINE; CHLOROFORM; CLOMIFENE CITRATE; FLAVONOID; HEXANE; LACTIC ACID; PHENOL DERIVATIVE; POLYPHENOL; PROPIDIUM IODIDE; PROPOLIS; SOLVENT; SULFORHODAMINE B; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL METABOLISM; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; GLUCOSE INTAKE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IN VITRO STUDY;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; GLYCOLYSIS; HUMANS; PLANT EXTRACTS; PORTUGAL; PROPOLIS;

EID: 84880334946     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-184     Document Type: Article

References (48)

1. Bankova VS, Popov SS, Marekov NL. A study on flavonoids of propolis. J Nat Prod 1983, 46:471-474.
2. Marcucci MC. Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 1995, 26(2):83-99.
3. Bankova V. Chemical diversity of propolis and the problem of standardization. J Ethnopharmacol 2005, 100(1-2):114-117.
4. Bankova VS, De Castro SL, Marcucci MC. Propolis: recent advances in chemistry and plant origin. Apidologie 2000, 31:3-15.
5. Greenaway W, Scaysbrook T, Whatley FR. The composition and plant origins of propolis: a report of work at Oxford. Bee World 1990, 71(3):107-118.
6. Falcao SI, Vilas-Boas M, Estevinho LM, Barros C, Domingues MR, Cardoso SM. Phenolic characterization of Northeast Portuguese propolis: usual and unusual compounds. Anal Bioanal Chem 2010, 396(2):887-897. 10.1007/s00216-009-3232-8, 19902191.
7. Scazzocchio F, D'Auria FD, Alessandrini D, Pantanella F. Multifactorial aspects of antimicrobial activity of propolis. Microbiol Res 2006, 161(4):327-333. 10.1016/j.micres.2005.12.003, 16427259.
8. Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol 1999, 64(3):235-240. 10.1016/S0378-8741(98)00131-7, 10363838.
9. Silici S, Koc NA, Ayangil D, Cankaya S. Antifungal activities of propolis collected by different races of honeybees against yeasts isolated from patients with superficial mycoses. J Pharmacol Sci 2005, 99(1):39-44. 10.1254/jphs.FPE05002X, 16141640.
10. Amoros M, Simoes CM, Girre L, Sauvager F, Cormier M. Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture comparison with the antiviral activity of propolis. J Nat Prod 1992, 55(12):1732-1740. 10.1021/np50090a003, 1338212.
11. Mirzoeva OK, Calder PC. The effect of propolis and its components on eicosanoid production during the inflammatory response. Prostaglandins Leukot Essent Fatty Acids 1996, 55(6):441-449. 10.1016/S0952-3278(96)90129-5, 9014224.
12. Hu F, Hepburn HR, Li Y, Chen M, Radloff SE, Daya S. Effects of ethanol and water extracts of propolis (bee glue) on acute inflammatory animal models. J Ethnopharmacol 2005, 100(3):276-283. 10.1016/j.jep.2005.02.044, 15899563.
13. Valente MJ, Baltazar AF, Henrique R, Estevinho L, Carvalho M. Biological activities of Portuguese propolis: protection against free radical-induced erythrocyte damage and inhibition of human renal cancer cell growth in vitro. Food Chem Toxicol 2011, 49(1):86-92. 10.1016/j.fct.2010.10.001, 20934479.
14. Russo A, Longo R, Vanella A. Antioxidant activity of propolis: role of caffeic acid phenethyl ester and galangin. Fitoterapia 2002, 73(Suppl 1):S21-S29.
15. Seo KW, Park M, Song YJ, Kim SJ, Yoon KR. The protective effects of Propolis on hepatic injury and its mechanism. Phytother Res 2003, 17(3):250-253. 10.1002/ptr.1120, 12672155.
16. Pagliarone AC, Orsatti CL, Bufalo MC, Missima F, Bachiega TF, Junior JP, Sforcin JM. Propolis effects on pro-inflammatory cytokine production and Toll-like receptor 2 and 4 expression in stressed mice. Int Immunopharmacol 2009, 9(11):1352-1356. 10.1016/j.intimp.2009.08.005, 19699326.
17. Lin WL, Liang WH, Lee YJ, Chuang SK, Tseng TH. Antitumor progression potential of caffeic acid phenethyl ester involving p75(NTR) in C6 glioma cells. Chem Biol Interact 2010, 188(3):607-615. 10.1016/j.cbi.2010.09.002, 20836997.
18. Oršolić N, Bašić I. Water-soluble derivative of propolis and its polyphenolic compounds enhance tumoricidal activity of macrophages. J Ethnopharmacol 2005, 102(1):37-45. 10.1016/j.jep.2005.05.036, 16054317.
19. Basini G, Baioni L, Bussolati S, Grasselli F, Daquino C, Spatafora C, Tringali C. Antiangiogenic properties of an unusual benzo [k, l] xanthene lignan derived from CAPE (Caffeic Acid Phenethyl Ester). Invest New Drugs 2012, 30(1):186-190. 10.1007/s10637-010-9550-z, 20924642.
20. Miguel MG, Nunes S, Dandlen SA, Cavaco AM, Antunes MD. Phenols and antioxidant activity of hydro-alcoholic extracts of propolis from Algarve South of Portugal. Food Chem Toxicol 2010, 48(12):3418-3423. 10.1016/j.fct.2010.09.014, 20849908.
21. Moreira L, Dias LG, Pereira JA, Estevinho L. Antioxidant properties, total phenols and pollen analysis of propolis samples from Portugal. Food Chem Toxicol 2008, 46(11):3482-3485. 10.1016/j.fct.2008.08.025, 18804144.
22. Shim CK, Cheon EP, Kang KW, Seo KS, Han HK. Inhibition effect of flavonoids on monocarboxylate transporter 1 (MCT1) in Caco-2 cells. J Pharm Pharmacol 2007, 59(11):1515-1519. 10.1211/jpp.59.11.0008, 17976262.
23. Wang Q, Morris ME. Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. Drug Metab Dispos 2007, 35(2):201-208.
24. Colen CB, Shen Y, Ghoddoussi F, Yu P, Francis TB, Koch BJ, Monterey MD, Galloway MP, Sloan AE, Mathupala SP. Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study. Neoplasia 2011, 13(7):620-632. 3132848, 21750656.
25. Coss RA, Storck CW, Daskalakis C, Berd D, Wahl ML. Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells. Mol Cancer Ther 2003, 2(4):383-388.
26. Fang J, Quinones QJ, Holman TL, Morowitz MJ, Wang Q, Zhao H, Sivo F, Maris JM, Wahl ML. The H + -linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. Mol Pharmacol 2006, 70(6):2108-2115. 10.1124/mol.106.026245, 17000864.
27. Singleton VL, Orthofer R, Lamuela-Raventós RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. Methods Enzymol 1999, 299:152-178.
28. Woisky RG, Salatino A. Analysis of propolis: some parameters and procedures for chemical quality control. J Apicult Res 1999, 37(2):99-105.
29. Pereira A, Seixas F, Silva M. Propolis: 100 years of research and future perspectives. Soc Brasileira Quimica 2002, 25(2):321-326.
30. Ishihara M, Naoi K, Hashita M, Itoh Y, Suzui M. Growth inhibitory activity of ethanol extracts of Chinese and Brazilian propolis in four human colon carcinoma cell lines. Oncol Rep 2009, 22(2):349-354.
31. Szliszka E, Czuba ZP, Bronikowska J, Mertas A, Paradysz A, Krol W. Ethanolic extract of propolis augments TRAIL-induced apoptotic death in prostate cancer cells. Evid Based Complement Alternat Med 2011,
32. Li F, Awale S, Tezuka Y, Kadota S. Cytotoxicity of constituents from Mexican propolis against a panel of six different cancer cell lines. Nat Prod Commun 2010, 5(10):1601-1606.
33. Pratsinis H, Kletsas D, Melliou E, Chinou I. Antiproliferative activity of Greek propolis. J Med Food 2010, 13(2):286-290. 10.1089/jmf.2009.0071, 20132046.
34. Russo A, Cardile V, Sanchez F, Troncoso N, Vanella A, Garbarino JA. Chilean propolis: antioxidant activity and antiproliferative action in human tumor cell lines. Life Sci 2004, 76(5):545-558. 10.1016/j.lfs.2004.07.019, 15556167.
35. Banskota AH, Nagaoka T, Sumioka LY, Tezuka Y, Awale S, Midorikawa K, Matsushige K, Kadota S. Antiproliferative activity of the Netherlands propolis and its active principles in cancer cell lines. J Ethnopharmacol 2002, 80(1):67-73. 10.1016/S0378-8741(02)00022-3, 11891088.
36. Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 2008, 52(5):507-526. 10.1002/mnfr.200700326, 18435439.
37. Kim WK, Bang MH, Kim ES, Kang NE, Jung KC, Cho HJ, Park JH. Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. J Nutr Biochem 2005, 16(3):155-162. 10.1016/j.jnutbio.2004.10.010, 15741050.
38. Dihal AA, Woutersen RA, Van Ommen B, Rietjens IM, Stierum RH. Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2. Cancer Lett 2006, 238(2):248-259. 10.1016/j.canlet.2005.07.007, 16129554.
39. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 2007, 18(7):427-442. 10.1016/j.jnutbio.2006.11.004, 17321735.
40. Turktekin M, Konac E, Onen HI, Alp E, Yilmaz A, Menevse S. Evaluation of the effects of the flavonoid apigenin on apoptotic pathway gene expression on the colon cancer cell line (HT29). J Med Food 2011, 14(10):1107-1117. 10.1089/jmf.2010.0208, 21548803.
41. Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, Birt DF. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog 2000, 28(2):102-110. 10.1002/1098-2744(200006)28:2<102::AID-MC6>3.0.CO;2-2, 10900467.
42. Goncalves P, Araujo JR, Pinho MJ, Martel F. In vitro studies on the inhibition of colon cancer by butyrate and polyphenolic compounds. Nutr Cancer 2011, 63(2):282-294. 10.1080/01635581.2011.523166, 21207318.
43. Kuntz S, Wenzel U, Daniel H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr 1999, 38(3):133-142. 10.1007/s003940050054, 10443335.
44. Ekmekcioglu C, Feyertag J, Marktl W. Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2 cells. Cancer Lett 1998, 128(2):137-144. 10.1016/S0304-3835(98)00073-1, 9683274.
45. Xiang D, Wang D, He Y, Xie J, Zhong Z, Li Z. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling. Anticancer Drugs 2006, 17(7):753-762. 10.1097/01.cad.0000224441.01082.bb, 16926625.
46. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 2004, 4(11):891-899. 10.1038/nrc1478, 15516961.
47. Kaelin WG, Thompson CB. Q&A: cancer: clues from cell metabolism. Nature 2010, 465:562-564. 10.1038/465562a, 20520704.
48. Pinheiro C, Longatto-Filho A, Azevedo-Silva J, Casal M, Schmitt FC, Baltazar F. Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr 2012, 44:127-139. 10.1007/s10863-012-9428-1, 22407107.